US Bancorp’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.43M | Buy |
10,103
+8,132
| +413% | +$1.78M | ﹤0.01% | 854 |
|
|
2026
Q1 | $373K | Sell |
1,971
-989
| -33% | -$173K | ﹤0.01% | 1657 |
|
|
2025
Q4 | $503K | Sell |
2,960
-323
| -10% | -$49.5K | ﹤0.01% | 1530 |
|
|
2025
Q3 | $433K | Buy |
3,283
+1,730
| +111% | +$208K | ﹤0.01% | 1595 |
|
|
2025
Q2 | $165K | Sell |
1,553
-809
| -34% | -$87.9K | ﹤0.01% | 2152 |
|
|
2025
Q1 | $293K | Sell |
2,362
-39
| -2% | -$5.09K | ﹤0.01% | 1800 |
|
|
2024
Q4 | $296K | Buy |
2,401
+38
| +2% | +$4.48K | ﹤0.01% | 1807 |
|
|
2024
Q3 | $263K | Sell |
2,363
-69
| -3% | -$7.56K | ﹤0.01% | 1887 |
|
|
2024
Q2 | $260K | Buy |
2,432
+847
| +53% | +$93.1K | ﹤0.01% | 1855 |
|
|
2024
Q1 | $191K | Sell |
1,585
-57
| -3% | -$6.98K | ﹤0.01% | 2035 |
|
|
2023
Q4 | $202K | Sell |
1,642
-100
| -6% | -$12.5K | ﹤0.01% | 2004 |
|
|
2023
Q3 | $225K | Sell |
1,742
-1
| -0.1% | -$133 | ﹤0.01% | 1777 |
|
|
2023
Q2 | $216K | Sell |
1,743
-180
| -9% | -$24.2K | ﹤0.01% | 1831 |
|
|
2023
Q1 | $281K | Sell |
1,923
-52
| -3% | -$7.69K | ﹤0.01% | 1708 |
|
|
2022
Q4 | $315K | Buy |
1,975
+310
| +19% | +$45.4K | ﹤0.01% | 1625 |
|
|
2022
Q3 | $222K | Sell |
1,665
-292
| -15% | -$44.4K | ﹤0.01% | 1789 |
|
|
2022
Q2 | $305K | Sell |
1,957
-779
| -28% | -$120K | ﹤0.01% | 1688 |
|
|
2022
Q1 | $427K | Buy |
2,736
+322
| +13% | +$46.7K | ﹤0.01% | 1602 |
|
|
2021
Q4 | $308K | Sell |
2,414
-300
| -11% | -$39.4K | ﹤0.01% | 1776 |
|
|
2021
Q3 | $353K | Sell |
2,714
-634
| -19% | -$95.8K | ﹤0.01% | 1691 |
|
|
2021
Q2 | $595K | Sell |
3,348
-880
| -21% | -$152K | ﹤0.01% | 1454 |
|
|
2021
Q1 | $695K | Buy |
4,228
+370
| +10% | +$60.9K | ﹤0.01% | 1332 |
|
|
2020
Q4 | $638K | Sell |
3,858
-2,429
| -39% | -$362K | ﹤0.01% | 1322 |
|
|
2020
Q3 | $896K | Sell |
6,287
-12,204
| -66% | -$1.51M | ﹤0.01% | 1050 |
|
|
2020
Q2 | $2.04M | Buy |
18,491
+946
| +5% | +$105K | 0.01% | 713 |
|
|
2020
Q1 | $1.75M | Buy |
17,545
+2,705
| +18% | +$350K | 0.01% | 707 |
|
|
2019
Q4 | $2.21M | Sell |
14,840
-2,505
| -14% | -$341K | 0.01% | 742 |
|
|
2019
Q3 | $2.22M | Buy |
17,345
+1,077
| +7% | +$144K | 0.01% | 726 |
|
|
2019
Q2 | $2.32M | Buy |
16,268
+1,444
| +10% | +$194K | 0.01% | 724 |
|
|
2019
Q1 | $2.12M | Buy |
14,824
+957
| +7% | +$125K | 0.01% | 743 |
|
|
2018
Q4 | $1.72M | Sell |
13,867
-1,779
| -11% | -$264K | 0.01% | 791 |
|
|
2018
Q3 | $2.63M | Buy |
15,646
+3,946
| +34% | +$679K | 0.01% | 706 |
|
|
2018
Q2 | $2.02M | Buy |
11,700
+10,547
| +915% | +$1.72M | 0.01% | 800 |
|
|
2018
Q1 | $175K | Buy |
1,153
+66
| +6% | +$9.68K | ﹤0.01% | 1938 |
|
|
2017
Q4 | $147K | Buy |
1,087
+360
| +50% | +$49.9K | ﹤0.01% | 2055 |
|
|
2017
Q3 | $107K | Sell |
727
-31
| -4% | -$4.69K | ﹤0.01% | 2189 |
|
|
2017
Q2 | $118K | Buy |
758
+368
| +94% | +$56.3K | ﹤0.01% | 2109 |
|
|
2017
Q1 | $56K | Sell |
390
-38
| -9% | -$4.95K | ﹤0.01% | 2428 |
|
|
2016
Q4 | $46K | Sell |
428
-679
| -61% | -$75.6K | ﹤0.01% | 2485 |
|
|
2016
Q3 | $135K | Sell |
1,107
-399
| -26% | -$53.8K | ﹤0.01% | 1937 |
|
|
2016
Q2 | $213K | Buy |
1,506
+694
| +85% | +$102K | ﹤0.01% | 1695 |
|
|
2016
Q1 | $106K | Sell |
812
-1,004
| -55% | -$125K | ﹤0.01% | 1978 |
|
|
2015
Q4 | $256K | Sell |
1,816
-1,455
| -44% | -$202K | ﹤0.01% | 1588 |
|
|
2015
Q3 | $434K | Sell |
3,271
-86
| -3% | -$14.8K | ﹤0.01% | 1355 |
|
|
2015
Q2 | $591K | Sell |
3,357
-76
| -2% | -$13.6K | ﹤0.01% | 1273 |
|
|
2015
Q1 | $594K | Sell |
3,433
-247
| -7% | -$42.4K | ﹤0.01% | 1279 |
|
|
2014
Q4 | $603K | Sell |
3,680
-1,305
| -26% | -$217K | ﹤0.01% | 1244 |
|
|
2014
Q3 | $801K | Buy |
4,985
+1,375
| +38% | +$211K | ﹤0.01% | 1077 |
|
|
2014
Q2 | $531K | Buy |
3,610
+1,329
| +58% | +$184K | ﹤0.01% | 1315 |
|
|
2014
Q1 | $316K | Sell |
2,281
-1,571
| -41% | -$236K | ﹤0.01% | 1547 |
|
|
2013
Q4 | $488K | Buy |
3,852
+1,024
| +36% | +$106K | ﹤0.01% | 1316 |
|
|
2013
Q3 | $260K | Buy |
2,828
+1,246
| +79% | +$101K | ﹤0.01% | 1551 |
|
|
2013
Q2 | $109K | Buy |
+1,582
| New | +$96.7K | ﹤0.01% | 1974 |
|
Other funds holding JAZZ
US Bancorp's JAZZ Position: Q2 2026 in Review
US Bancorp increased its Jazz Pharmaceuticals (JAZZ) stake by 413% in Q2 2026, buying an estimated $1.78M and bringing the position to 10,103 shares worth $2.43M. The position accounts for ﹤0.01% of the portfolio, ranked #854.
US Bancorp first reported a position in JAZZ in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.63M in Q3 2018. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- US Bancorp held 10,103 shares of Jazz Pharmaceuticals worth $2.43M as of Q2 2026.
- US Bancorp bought 8,132 Jazz Pharmaceuticals shares in Q2 2026, an estimated $1.78M.
- Jazz Pharmaceuticals made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #854 holding.
- US Bancorp first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- US Bancorp's Jazz Pharmaceuticals position peaked at $2.63M in Q3 2018.
- 641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.